Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmore is a German specialty pharmaceutical company that focuses on the development, registration, and distribution of niche medicinal products for the hospital and retail pharmacy markets. The company specializes in critical care therapeutic areas, including intensive care, emergency medicine, oncology, and neurology. Pharmore provides essential medications such as antidotes and oncology supportive care treatments, leveraging its expertise in the German regulatory environment. In July 2022, the company was acquired by Ethypharm, a French specialty pharmaceutical group, to serve as a platform for Ethypharm's expansion into the German hospital sector. The integration allows Pharmore to offer a broader range of products while maintaining its focus on high-quality, specialized patient care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmore.